Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

The Association of Fludarabin, Oral Busulfan and Thymoglobulin Prior to Matched-Related Allo-SCT Allows for High Long Term Outcome for Both Patients with Myeloid or Lymphoid Malignancies and Reveals the Impact of CD34+ Graft Cell Dose On Cgvhd and Outcome: Long Term Analysis of a Homogenous Cohort of 100 Consecutive Patients.

Didier Blaise, MD, Laure Farnaut, Benjamin Esterni, MSc, Catherine Faucher, MD, Sabine Furst, MD, Jean El Cheikh, MD, Patrick Ladaique, MD, Norbert Vey, MD, Reda Bouabdallah, MD, Anne Marie Stoppa, MD, Claude Lemarie, Boris Calmels, Luca Castagna, MD, Mohamad Mohty, MD, PhD, Christian Chabannon, MD, PhD

Blood (2009) 114 (22): 3374.

https://doi.org/10.1182/blood.V114.22.3374.3374

Published: 2009

Journal Articles

Donor Stem Cell Source Does Not Impact Outcome of High Risk (HR) Acute Myeloblastic Leukaemia (AML) Patients After Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation (RIC-ALLO).

Sabine Furst, MD, Luca Castagna, MD, Thomas Prébet, MD, Claude Lemarie, Jean El Cheikh, MD, Catherine Faucher, MD, Norbert Vey, MD, Aude Charbonnier, MD, PhD, Patrick Ladaique, MD, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2009) 114 (22): 4339.

https://doi.org/10.1182/blood.V114.22.4339.4339

Published: 2009

Journal Articles

Graft-Versus Host Disease (GVHD) and Infectious Complications Following Reduced Intensity Conditioning (RIC) Umbilical Cord Blood Transplantation (UCBT) in Adults.

Sabine Furst, MD, Mohamad Mohty, MD, PhD, Catherine Faucher, MD, Jean El-Cheikh, MD, Patrick Ladaique, MD, Claude Lemarie, Norbert Vey, MD, Reda Bouabdallah, MD, Anne-Marie Stoppa, MD, Nicolas Marchetti, MD, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2007) 110 (11): 4985.

https://doi.org/10.1182/blood.V110.11.4985.4985

Published: 2007

Journal Articles

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients with Acute Myeloid Leukemia (AML): Long Term Results of a “Donor” Versus “No Donor” Comparison.

Mohamad Mohty, MD, PhD, Hugues de Lavallade, MD, Jean El-Cheikh, MD, Patrick Ladaique, MD, Catherine Faucher, MD, Sabine Furst, MD, Norbert Vey, MD, Diane Coso, MD, Anne-Marie Stoppa, MD, Jean-Albert Gastaut, MD, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2007) 110 (11): 1090.

https://doi.org/10.1182/blood.V110.11.1090.1090

Published: 2007

Journal Articles

Early Post-Transplant Administration of Recombinant Erythropoietin Decreases Transfusion Needs and Hastens Haemoglobin Reconstitution in Reduced Intensity Conditioned (RIC) Allogeneic Stem Cell Transplantation (ASCT) for Non-Myeloid Malignancies.

Vadim Ivanov, MD, Catherine Faucher, MD, Patrick Ladaique, MD, Sabine Furst, MD, Mohamad Mothy, MD, Jean El Cheikh, MD, Thomas Prebet, MD, Diane Coso, MD, Jean-Marc Schiano, MD, Frederic Viret, MD, Christian Chabannon, MD, Didier Blaise, MD

Blood (2007) 110 (11): 2997.

https://doi.org/10.1182/blood.V110.11.2997.2997

Published: 2007

Journal Articles

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) as Salvage Treatment for Relapsing Multiple Myeloma (MM): A “Donor” vs. “No Donor” Comparison.

Hugues de Lavallade, MD, Patrick Ladaique, MD, Catherine Faucher, MD, Sabine Furst, MD, Jean El-Cheikh, MD, Anne-Marie Stoppa, MD, Diane Coso, MD, Reda Bouabdallah, MD, Norbert Vey, MD, Danielle Sainty, MD, Christian Chabannon, MD, PhD, Jean-Albert Gastaut, MD, Didier Blaise, MD, Mohamad Mohty, MD, PhD

Blood (2006) 108 (11): 3003.

https://doi.org/10.1182/blood.V108.11.3003.3003

Published: 2006

Journal Articles

Platelets Recovery and Transfusion Needs after Reduced Intensity Conditioning (RIC) Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation (allo-SCT).

Thomas Prebet, MD, Mohamad Mohty, MD, PhD, Patrick Ladaique, MD, Christian Chabannon, MD,PhD, Catherine Faucher, MD, Sabine Furst, MD, Hugues de Lavallade, MD, Jean El-Cheikh, MD, Patrice Viens, MD, Jean-Albert Gastaut, MD, Didier Blaise, MD

Blood (2006) 108 (11): 2989.

https://doi.org/10.1182/blood.V108.11.2989.2989

Published: 2006

NARROW

Donor Stem Cell Source Does Not Impact Outcome of High Risk (HR) Acute Myeloblastic Leukaemia (AML) Patients After Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation (RIC-ALLO).

Graft-Versus Host Disease (GVHD) and Infectious Complications Following Reduced Intensity Conditioning (RIC) Umbilical Cord Blood Transplantation (UCBT) in Adults.

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients with Acute Myeloid Leukemia (AML): Long Term Results of a “Donor” Versus “No Donor” Comparison.

Early Post-Transplant Administration of Recombinant Erythropoietin Decreases Transfusion Needs and Hastens Haemoglobin Reconstitution in Reduced Intensity Conditioned (RIC) Allogeneic Stem Cell Transplantation (ASCT) for Non-Myeloid Malignancies.

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) as Salvage Treatment for Relapsing Multiple Myeloma (MM): A “Donor” vs. “No Donor” Comparison.

Platelets Recovery and Transfusion Needs after Reduced Intensity Conditioning (RIC) Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation (allo-SCT).

Email alerts

ASH Publications

American Society of Hematology

Donor Stem Cell Source Does Not Impact Outcome of High Risk (HR) Acute Myeloblastic Leukaemia (AML) Patients After Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation (RIC-ALLO).

Graft-Versus Host Disease (GVHD) and Infectious Complications Following Reduced Intensity Conditioning (RIC) Umbilical Cord Blood Transplantation (UCBT) in Adults.

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients with Acute Myeloid Leukemia (AML): Long Term Results of a “Donor” Versus “No Donor” Comparison.

Early Post-Transplant Administration of Recombinant Erythropoietin Decreases Transfusion Needs and Hastens Haemoglobin Reconstitution in Reduced Intensity Conditioned (RIC) Allogeneic Stem Cell Transplantation (ASCT) for Non-Myeloid Malignancies.

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) as Salvage Treatment for Relapsing Multiple Myeloma (MM): A “Donor” vs. “No Donor” Comparison.

Platelets Recovery and Transfusion Needs after Reduced Intensity Conditioning (RIC) Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation (allo-SCT).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only